Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.
A group of 54 patients with rheumatoid arthritis (31 fast, 23 slow acetylators) treated with sulphasalazine 3 g/day were studied retrospectively. At 24 weeks no difference in the efficacy of the drug could be shown between fast and slow acetylators. In a second prospective study 40 fast acetylators...
محفوظ في:
| الحاوية / القاعدة: | Ann Rheum Dis |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMJ Publishing Group
1985
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2867746/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.44.12.831 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|